March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc

First Page		Document Content
Date: 2011-03-04 17:07:37 Anticonvulsants Topiramate Treatment of bipolar disorder Pharmacology Ortho-McNeil-Janssen Ortho-McNeil Pharmaceutical Food and Drug Administration Pregnancy Johnson & Johnson Medicine Chemistry		March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc Add to Reading List Source URL: www.topamaxepilepsy.com Download Document from Source Website File Size: 216,00 KB Share Document on Facebook

	The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS DocID: 1sHB2 - View Document
	Health Net Behavioral Health Benefit Plan DocID: 1rmb0 - View Document
	Newsletter June 2016 We would like to draw your attention to the Call for Applications: "IZA/DFID Short Course on Programme Evaluation" deadline which is June 30th__________________________________________________ DocID: 1r8XM - View Document
	This list of services may change from year to year and are unique to Blue Cross Community Centennial:   DocID: 1qObB - View Document
	Newsletter 19 (Summer 2016)V3.pub DocID: 1qylx - View Document